Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Levothyroxine Sodium

CompanyNorthwind Pharmaceuticals (DUNS: 036986393)

Effective Date

January 22, 2015

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Levothyroxine(0.1 mg in 1 1)

Registrants (1)

Northwind Pharmaceuticals

DUNS Number

036986393

Manufacturing Establishments (1)

Northwind Pharmaceuticals

Labeler

Northwind Pharmaceuticals

Registrant

Northwind Pharmaceuticals

DUNS Number

036986393

Products (1)

Levothyroxine Sodium

NDC Product Code

51655-295

Application Number

NDA021342

Marketing Category

NDA (C73594)

Route of Administration

ORAL

Effective Date

January 23, 2015

Ingredients

LevothyroxineActive

Code: 9J765S329GClass: ACTIRQuantity: 0.1 mg in 1 1

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy